Cargando…
Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
Hypomyelinating leukodystrophies (HLDs) represent a group of congenital rare diseases for which the responsible genes have been identified in recent studies. In this review, we briefly describe the genetic/molecular mechanisms underlying the pathogenesis of HLD and the normal cellular functions of t...
Autores principales: | Torii, Tomohiro, Yamauchi, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538087/ https://www.ncbi.nlm.nih.gov/pubmed/37755363 http://dx.doi.org/10.3390/neurolint15030072 |
Ejemplares similares
-
Defective myelination in mice harboring hypomyelinating leukodystrophy-associated HSPD1 mutation
por: Miyamoto, Yuki, et al.
Publicado: (2017) -
Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation
por: Matsumoto, Naoto, et al.
Publicado: (2019) -
Data on the effect of hypomyelinating leukodystrophy 6 (HLD6)-associated mutations on the TUBB4A properties
por: Miyamoto, Yuki, et al.
Publicado: (2017) -
Defective oligodendrocyte differentiation by hypomyelinating leukodystrophy 13 (HLD13)-associated mutation of Hikeshi
por: Miyamoto, Yuki, et al.
Publicado: (2023) -
Hypomyelinating Leukodystrophy 10 (HLD10)-Associated Mutations of PYCR2 Form Large Size Mitochondria, Inhibiting Oligodendroglial Cell Morphological Differentiation
por: Torii, Tomohiro, et al.
Publicado: (2022)